Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: a population-based study.

Savola, Kaisa; Laara, Esa; Vahasalo, Paula; Kulmala, Petri; Akerblom, Hans K.; Knip, Mikael; Savola, K; Läärä, E; Vähäsalo, P; Kulmala, P; Akerblom, H K; Knip, M; Childhood Diabetes in Finland Study Group

To study the dynamics of disease-associated humoral immune responses, we analyzed autoantibodies to the IA-2 protein (IA-2A), glutamic acid decarboxylase (GADA), and insulin (IAA) and also islet cell antibodies (ICA) in a population-based, prospective, representative series of 710 siblings (<20 years of age) of children with type 1 diabetes. Positivity for single autoantibodies was observed in 8-13% of these siblings during an average follow-up of 4 years. The overall incidence rates per 1,000 years (number of cases/person-years in parentheses) for positive seroconversion of IA-2A were nine (19/2,123), followed by six (12/2,049) for GADA, 19 (40/2,111) for IAA, and 16 (31/1965) for ICA. Positive seroconversions seemed to be associated with a young age of the sibling, HLA DR3/DR4 heterozygosity, HLA identity, and a high initial number of detectable autoantibodies. The overall incidence rates per 1,000 years (number of cases/person-years in parentheses) for inverse seroconversion of IA-2A were 76 (12/157), followed by 42 (10/237) for GADA, 460 (32/70) for IAA, and 27 (9/331) for ICA. No consistent risk factor for inverse seroconversions was present, although seroconversions were most frequent in siblings with older age, male sex, HLA phenotypes other than DR3/DR4, a small family size, and no other autoantibodies detectable at seroconversion. Altogether, these observations indicate that beta-cell autoimmunity may be induced at any age in childhood and adolescence. HLA-conferred genetic disease susceptibility is a strong determinant of persistent beta-cell autoimmunity, but environmental factors may also contribute to such autoimmunity.

DIABETES; AUTOANTIBODIES; PANCREATIC beta cells; AUTOANTIBODY analysis; COMPARATIVE studies; ENZYMES; INSULIN; TYPE 1 diabetes; ISLANDS of Langerhans; LONGITUDINAL method; RESEARCH methodology; MEDICAL cooperation; RESEARCH; EVALUATION research

Diabetes, 2001, Vol 50, Issue 11, p2625

0012-1797

Academic Journal

10.2337/diabetes.50.11.2625